Centring women's voices in contraceptive innovation: building the case for an on-demand, pericoital pill.
作者信息
Sedgh GIlda, Frye Laura J, Gemzell-Danielsson Kristina, Kapp Nathalie, Afolabi Kayode, Boateng Angela A, Mulombe-Phiri Mary, Cameron Sharon, Manoj Kanya, Iyengar Kirti, Winskell Abigail Grace, Little Kristen M, Gibbs Susannah, Demise Eden, Bell Stephen
机构信息
Evidence & Learning Working Group, Self-Care Trailblazers Group, Philadelphia, Pennsylvania, USA.
FHI 360, Durham, North Carolina, USA.
出版信息
BMJ Sex Reprod Health. 2025 Jan 6;51(1):1-2. doi: 10.1136/bmjsrh-2024-202510.
Abstract
摘要
相似文献
1
Centring women's voices in contraceptive innovation: building the case for an on-demand, pericoital pill.将女性声音置于避孕创新的中心：为按需服用的性交后避孕药提供依据。
BMJ Sex Reprod Health. 2025 Jan 6;51(1):1-2. doi: 10.1136/bmjsrh-2024-202510.
2
Acceptability of an on-demand pericoital oral contraceptive pill: a systematic scoping review.按需性交后口服避孕药接受度的系统评价性综述。
Reprod Health. 2024 Jun 28;21(1):93. doi: 10.1186/s12978-024-01829-7.
3
Consumer perspectives on a pericoital contraceptive pill in India and Uganda.消费者对印度和乌干达的性交后避孕药的看法。
Int Perspect Sex Reprod Health. 2013 Dec;39(4):195-204. doi: 10.1363/3919513.
4
Women's perceptions of the pill's potential health risks in Sri Lanka.斯里兰卡女性对避孕药潜在健康风险的认知。
Asia Pac Popul J. 1987 Sep;2(3):39-56.
5
6
Women in larger bodies' experiences with contraception: a scoping review.大体重女性的避孕体验：范围综述。
Reprod Health. 2021 Apr 29;18(1):89. doi: 10.1186/s12978-021-01139-2.
7
Feasibility and Acceptability of LNG 1.5 mg as an On-Demand Pericoital Contraceptive in Ghana.LNG 1.5 毫克作为加纳按需性交避孕法的可行性和可接受性。
Stud Fam Plann. 2023 Sep;54(3):523-538. doi: 10.1111/sifp.12248. Epub 2023 Jul 18.
8
Men's Attitude Towards Contraception and Sexuality, Women's Empowerment, and Demand Satisfied for Family Planning in India.印度男性对避孕与性观念的态度、女性赋权以及计划生育需求的满足情况
Front Sociol. 2021 Dec 16;6:689980. doi: 10.3389/fsoc.2021.689980. eCollection 2021.
9
Modern contraceptive use among women in need of family planning in India: an analysis of the inequalities related to the mix of methods used.印度有计划生育需求的女性中现代避孕方法的使用情况：对与使用方法组合相关的不平等现象的分析。
Reprod Health. 2021 Aug 21;18(1):173. doi: 10.1186/s12978-021-01220-w.
10
The Contraceptive Pill in Ireland 1964-79: Activism, Women and Patient-Doctor Relationships.1964 - 1979年爱尔兰的避孕药：激进主义、女性与医患关系
Med Hist. 2020 Apr;64(2):195-218. doi: 10.1017/mdh.2020.3.
本文引用的文献
1
Acceptability of an on-demand pericoital oral contraceptive pill: a systematic scoping review.按需性交后口服避孕药接受度的系统评价性综述。
Reprod Health. 2024 Jun 28;21(1):93. doi: 10.1186/s12978-024-01829-7.
2
Feasibility and Acceptability of LNG 1.5 mg as an On-Demand Pericoital Contraceptive in Ghana.LNG 1.5 毫克作为加纳按需性交避孕法的可行性和可接受性。
Stud Fam Plann. 2023 Sep;54(3):523-538. doi: 10.1111/sifp.12248. Epub 2023 Jul 18.
3
Feasibility of e-commerce pharmacy provision and acceptability of levonorgestrel 1.5 mg for pericoital use in urban and peri-urban settings in Kenya: a prospective cohort study.肯尼亚城市和城郊环境中电子商务药店供应的可行性以及左炔诺孕酮 1.5 毫克用于性交后避孕的可接受性：一项前瞻性队列研究。
BMJ Sex Reprod Health. 2023 Jan;49(1):35-42. doi: 10.1136/bmjsrh-2022-201653. Epub 2022 Nov 2.
4
Potential candidate for oral pericoital contraception: evaluating ulipristal acetate plus cyclo-oxygenase-2 inhibitor for ovulation disruption.口服性交后避孕的潜在候选药物：评估醋酸乌利司他联合环氧化酶-2抑制剂对排卵的干扰作用。
BMJ Sex Reprod Health. 2022 Jul;48(3):217-221. doi: 10.1136/bmjsrh-2021-201446. Epub 2022 Apr 25.
5
Accelerate progress-sexual and reproductive health and rights for all: report of the Guttmacher-Lancet Commission.加速进步——人人享有性与生殖健康及权利：古特马赫-柳叶刀委员会报告
Lancet. 2018 Jun 30;391(10140):2642-2692. doi: 10.1016/S0140-6736(18)30293-9. Epub 2018 May 9.
6
A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.一项前瞻性、开放标签、单臂、多中心研究，旨在评估使用1.5毫克左炔诺孕酮进行性交后口服避孕的有效性、安全性和可接受性。
Hum Reprod. 2016 Mar;31(3):530-40. doi: 10.1093/humrep/dev341. Epub 2016 Jan 31.
Zotero 插件